UPDATE 1-Myovant Sciences' uterine fibroids combo therapy meets main goal in study
May 14, 2019 at 08:07 AM EDT
Myovant Sciences Ltd said on Tuesday its combination therapy met the main goal of a late-stage study testing the treatment in women with uterine fibroids.
